hdac3 (Santa Cruz Biotechnology)
Structured Review

Hdac3, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 539 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hdac3/product/Santa Cruz Biotechnology
Average 94 stars, based on 539 article reviews
Images
1) Product Images from "Mechanisms inducing differentiation of adult islet progenitor-like cells into functional islet-like organoids"
Article Title: Mechanisms inducing differentiation of adult islet progenitor-like cells into functional islet-like organoids
Journal: Frontiers in Transplantation
doi: 10.3389/frtra.2026.1740314
Figure Legend Snippet: Requirement of CN/NFAT signaling to recruit p300 to RFX6 and NEUROD1 promoters during ISX9-induced IPC islet organoid differentiation (A) induction of NFAT family isoform genes in IPC clusters treated with ISX9 for 24 h in the presence of CN inhibitor FK506. (B) RFX6 and NEUROD1 promoter activation by ISX9 in IPCs in the presence of FK506 or transfected with gene vectors overexpressing dominant negative NFAT (dnNFAT) and mutated control (dnNFATm). (C) ChIP assay of association of NFATC2, p300, HDAC1, HDAC2, and HDAC3 with RFX6, NEUROD1, and NEUROG3 promoters upon 6 h treatment of IPCs with ISX9 with and without 24 h pretreatment with ITF2357. Graphed values are expressed as mean ± SD. Asterisks above bars indicate statistically significant differences (* p < 0.05, *** p < 0.001) in mean values for treatments based on a two-way ANOVA and Sidak's multiple comparison test. Data shown are results from at least three independent experiments using IPCs derived from three individual donors.
Techniques Used: Activation Assay, Transfection, Dominant Negative Mutation, Control, Comparison, Derivative Assay


